4SCAR19 Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 4SCAR19 Cells, covering 2016-11-18 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia [Phase 1]